
### [NCIT:C4116](http://purl.obolibrary.org/obo/NCIT_C4116)
**Label:** Stage 0 Transitional Cell Carcinoma

**Subclasses:** [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) 47.49%
- [NCIT:C36767](http://purl.obolibrary.org/obo/NCIT_C36767) (Abnormal Transitional Cell) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 47.49%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 47.49%


